Researchers funded by the National Institutes of Health have developed a prototype genetic test with the potential to predict the development and eventual severity of uterine fibroids—benign, but sometimes painful and debilitating tumors of the uterus. The test could be used to identify fibroid cases early and to better understand how they develop and how to treat them.
News
NICHD issues News Releases and Media Advisories to the news media. Spotlight and Research Feature articles explain NICHD research findings and public health issues to the general public. An Item of Interest is a short announcement of relevant information, such as a notable staff change.
Spotlight: Selected NICHD Research Advances of 2021
Read about NICHD’s research findings and activities from 2021.
Science Update: Fibroid risk associated with ancestry among Black and white women, NIH-funded study suggests
Among American Black and white women, the risk and extent of fibroids—benign tumors of the uterus—are associated with ancestry to distinct regions and populations, suggests a study funded by the National Institutes of Health. The study provides information that may lead to insights on the origins and treatments for these common tumors.
Spotlight: Selected NICHD Research Advances of 2020
Read about NICHD’s research findings and activities from 2020.
Spotlight: Boosting women’s health by supporting menstruation research
NICHD has supported gynecologic and reproductive health research for decades. Learn more about its leading role in menstruation research.
Science Update: Drug-containing nanoparticles reduce size of fibroid tumors in mice
In a study of mice, NIH-funded researchers have developed a prototype technique for shrinking uterine fibroids—sometimes painful, noncancerous tumors that form in the uterus. The method involves encasing a tumor-killing drug in nano-sized spheres called liposomes and delivering them directly to the fibroids through the bloodstream. The findings set the stage for studies to determine if the method is safe and effective for treating fibroids in people.
Release: NIH scientists call attention to the impact of opioids on women and children
In an editorial, Diana W. Bianchi, M.D., NICHD Director and Matthew W. Gillman, M.D., S.M., emphasize that women and children bear a substantial burden of the U.S. opioid epidemic and that coordinated, long-term research is essential to filling knowledge gaps about how opioids affect women and children.
Podcast: Menstruation as a Diagnostic Tool for Women’s Health
Dr. Candace Tingen with NICHD’s Gynecological Health and Disease Branch speaks about the possibilities of tapping a woman’s menstrual cycle for signs of disease. Listen to our latest podcast.
Item of Interest: NICHD announces gynecologic health and disease research themes and scientific vision
The Gynecologic Health and Disease Branch recently published its scientific vision. The document summarizes its research themes, which provide direction for future research.
Focus on Women’s Health Research
NICHD research aims to improve understanding of diseases and conditions that affect women.
Getting to Know the New NICHD Director
NICHD Director Dr. Diana Bianchi shares some thoughts about joining NICHD.
Pelvic pain may be common among reproductive-age women, NIH study finds
A high proportion of reproductive-age women may be experiencing pelvic pain that goes untreated, according to a study by researchers from the National Institutes of Health and the University of Utah School of Medicine, Salt Lake City.
In Search of Answers for Those Struggling With Infertility
During National Infertility Awareness Week 2015, Dr. Alan Guttmacher explores the latest research in an article in the Huffington Po
May Wrap-Up: Promoting Women’s Health
Throughout May, the NICHD highlighted important information about women’s health, particularly women’s health research. These efforts coincided in part with National Women’s Health Week, from May 11 to 17.
Dr. Lisa Halvorson New Chief of Gynecologic Health and Disease Branch
Lisa M. Halvorson, M.D., has been named the new Chief of the Gynecologic Health and Disease Branch (GHDB), effective June 15, 2014, announced Dr. Catherine Spong, M.D., Director of the Division of Extramural Research.
April Wrap-Up: Raising Infertility Awareness
The NICHD spent the last month highlighting important information about infertility.
Learning about Infertility Research at the NIH
Conversation between Rebecca Lazeration and three NICHD researchers who are working to advance the field of reproduction science.
Infertility Awareness: Share the Facts
Check out our infographic to learn the facts, and share it to spread the word.
2012 Division of Intramural Research (DIR) Annual Report
With 11 research programs, more than 75 researchers, and more than 1,100 support staff, the NICHD's DIR is among the largest at the NIH. But with good reason—The NICHD's DIR also has one of the broadest research portfolios at the NIH, covering nearly all aspects of human development and reproduction.
Scientific Vision: The Next Decade
On December 5, 2012, the NICHD released the Scientific Vision: The Next Decade, the culmination of a collaborative process that began in 2011 to identify the most promising scientific opportunities for the Institute and the research community to pursue over the next decade. The Vision statement was made available during the NICHD’s 50th anniversary colloquium.
BACK TO TOP